Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention TrialJohn R Davies, Tracey Mell, Harriett Fuller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I studyMark R Albertella, Paul M Loadman, Philip H Jones, et al.Journal of Medicinal Chemistry|July 13, 2013
Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activityHelen M Sheldrake, Sandra Travica, Inger Johansson, et al.Small (Weinheim an Der Bergstrasse, Germany)|September 17, 2013
Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapyCelina Ansari, Grigory A Tikhomirov, Su Hyun Hong, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|April 24, 2021
Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4Antonia Charalambous, Victoria Mico, Laura E McVeigh, et al.Plos One|August 17, 2013
Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migrationYousef M J Al-Saraireh, Mark Sutherland, Bradley R Springett, et al.Molecular Cancer Therapeutics|June 30, 2017
A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts SurvivalSuchismita Mohanty, Zixin Chen, Kai Li, et al.Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Synthesis and biological evaluation of colchicine C-ring analogues tethered with aliphatic linkers suitable for prodrug derivatisationJérémie Fournier-Dit-Chabert, Victoria Vinader, Ana Rita Santos, et al.The Journal of Urology|September 6, 2006
Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancerRajiv Puri, Victor Palit, Paul M Loadman, et al.Journal of Medicinal Chemistry|September 1, 2006
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugatesGeoff Wells, Christopher R H Martin, Philip W Howard, et al.Pageof 8